Literature DB >> 2982897

Characterization of thyroxine-binding globulin secreted by a human hepatoma cell line.

Y Murata, D H Sarne, A L Horwitz, R Lecocq, D P Aden, B B Knowles, S Refetoff.   

Abstract

T4-binding globulin (TBG) is a glycoprotein synthesized by the liver and is the principal carrier of T4 and T3 in serum. In this report, we demonstrate that the Hep G2 cell line, derived from a human hepatoblastoma, synthesizes and secretes TBG, the properties of which were characterized. Hep G2 cells secreted TBG into the medium after more than 100 transfers in tissue culture conditions. At confluency and after changing to serum-free culture conditions, TBG accumulation into the medium was linear for 3 days and constituted approximately 0.16% of the proteins synthesized over 24 h. Its abundance relative to albumin is 10-fold greater than that found in normal human serum. TBG secreted by the Hep G2 cells was indistinguishable from native normal human serum TBG, as determined immunologically, by electrophoresis on polyacrylamide gel in denaturing and nondenaturing conditions, and by isoelectric focusing. It also specifically bound T4 and T3, albeit with slightly reduced affinity, and had increased heat lability. Although slightly different from normal serum TBG in caucasians, the physical and biological properties of the Hep G2-derived TBG are similar to those of the variant TBG found in the serum of some healthy Australian Aborigines.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982897     DOI: 10.1210/jcem-60-3-472

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Effects of the antileukemic drug L-asparaginase on sex hormone-binding globulin: studies in vivo and in vitro.

Authors:  L Bartalena; E Martino; A Pacchiarotti; S Balzano; M Falcone; V Sica; P Biddau; A Pinchera
Journal:  J Endocrinol Invest       Date:  1989 Jul-Aug       Impact factor: 4.256

2.  Induction of haem synthesis in Hep G2 human hepatoma cells by dimethyl sulphoxide. A transcriptionally activated event.

Authors:  R A Galbraith; S Sassa; A Kappas
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

3.  Sequence of the variant thyroxine-binding globulin of Australian aborigines. Only one of two amino acid replacements is responsible for its altered properties.

Authors:  K Takeda; Y Mori; S Sobieszczyk; H Seo; M Dick; F Watson; I L Flink; S Seino; G I Bell; S Refetoff
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  A novel variant in Serpina7 gene in a family with thyroxine-binding globulin deficiency.

Authors:  Rita Domingues; Paula Font; Luís Sobrinho; Maria João Bugalho
Journal:  Endocrine       Date:  2009-05-05       Impact factor: 3.633

5.  The differentiation-inducing agent sodium butyrate produces divergent effects on albumin and thyroxine-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.

Authors:  L Bartalena; F Bogazzi; G Donadel; E Martino; F Gabrielli; A Pinchera
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

6.  Hyperthyroxinaemia in hepatocellular carcinoma: relation to thyroid binding globulin in the clinical and preclinical stages of the disease.

Authors:  A Alexopoulos; W Hutchinson; A Bari; J J Keating; P J Johnson; R Williams
Journal:  Br J Cancer       Date:  1988-03       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.